Here are four things to know:
1. The Safety Using NUsurface, or SUN, trial will enroll approximately 120 patients with persistent knee pain.
2. It will include up to 20 sites nationwide.
3. NUsurface is meniscus replacement implant for patients with injured or deteriorating meniscus cartilages.
4. Active Implants first clinical trial for NUsurface, the VENUS Study, has been underway at 10 sites in the United States since January 2015.
More articles on devices:
All MACs to cover Osiris Therapeutics’ Grafix for wound care: 3 points
Bone Therapeutics, Kasios extend collaboration for spinal fusion product: 3 takeaways
Global outsourced orthopedic manufacturing market to reach $2B+ by 2020: 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
